Schedule 13G ownership disclosure

ANI Pharmaceuticals Inc

Security class unavailable · CUSIP: 00182C103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,175,529
Percent of class
10.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000215457-17-003547
Form type
SC 13G/A
Filer
ANI PHARMACEUTICALS INC
CIK
CIK 1023024
Filed
Aug 10, 2017
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub